Skip to content
Stock screener

EW Edwards Lifesciences Corp stock chart & analysis

Conviction 22HealthcareScan · Fri, Nov 6, 2026

Edwards Lifesciences Corp (EW) closed at $102.14 (+1.31%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 77, RS Rating 87, -2.0% from its 52-week high, +19.7% year to date. Sector: Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies.

EW$102.14+1.31%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Edwards Lifesciences CorpOrthopedic, Prosthetic & Surgical Appliances & Supplieswww.edwards.com ↗
Price102.14
Change+1.31%
Gap-1.56%
Rel volume0.77×
Avg volume4.6M
Avg $ vol426.01M
SMA 2091.31
SMA 5088.92
SMA 20085.77
Price vs 50+14.80%
Price vs 200+19.01%
MA stackbullish
50/200 cross—
Supertrendup · 91.64
RSI (14)77
MACD hist1.31
MACD cross—
Stoch %K / %D88 / 88
ADX (14)26
+DI / −DI32 / 12
RSI divergence—
MACD divergence—
ATR %2.96%
ADR %2.95%
52w high104.17
52w low74.66
From 52w high-2.00%
Above 52w low+36.73%
New 52w highYes
SqueezeOff
Bollinger width20.99%
%B1.06
Donchian pos89.37%
Donchian high104.17
Donchian low84.55
AVWAP (52w high)101.17
vs AVWAP high+0.90%
AVWAP (52w low)85.79
vs AVWAP low+18.98%
OBV trendUp
Chaikin MF (20)0.24
Today vs 20d0.77×
Avg vol (14d)4.96M
Avg vol (20d)4.6M
Avg $ vol (20d)426.01M
Market cap58.7B
RS Rating87 / 99
RS 3m (vs SPY)+15.79%
RS 6m (vs SPY)+27.96%
RS line new highYes
Trend template8/8
Technical rank94.9
1 week+10.94%
1 month+21.18%
3 months+10.92%
6 months+27.66%
1 year+23.23%
YTD+19.74%
P/E54.68
P/B5.40
P/S9.67
P/FCF43.97
EPS1.83
Div yield—
ROE9.88%
ROA7.59%
Debt/Eq0.06
Current4.60
EV/EBITDA39.54
Gross margin78.01%
Net margin17.69%
Rev growth11.55%
EPS growth-74.28%
Price target114.30
Target upside11.97%
Analyst ratingBuy
Institutional102.73%
Ent. value56.18B
Revenue1.72B
Net income307.5M
Gross profit1.35B
Free cash flow1.33B
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies
ExchangeNYSE
Shares out575.8M
Employees16K
ListedMon, Apr 3, 2000
Free float571.76M
Float %99.2%
Short interest—
Days to cover—
Short volume44.0%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$0.80 vs $0.73
Last surprise+9.6% beat
Setup gradeD
Conviction22 / 100
Pattern quality—
Tech rank94.9 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance89.68
Support83.46
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

EW technical analysis

Trend

EW is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 14.8% above the 50-day ($88.92) and 19.0% above the 200-day ($85.77). ADX(14) at 26 points to a strong, established trend. It meets 8 of 8 trend-template criteria.

Momentum

RSI(14) is 77, in overbought territory. The MACD histogram is positive. Its RS Rating of 87 puts its weighted 12-month performance ahead of about 87% of the US market, and its RS line is at a new high.

Volume and volatility

Volume on the latest session ran 0.8× its 20-day average. It trades about $426.0M a day on average. ATR(14) is $3.02, 3.0% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.24) shows accumulation.

Key levels

The chart pattern's support is $83.46 and its resistance $89.68. The 52-week range is $74.66 to $104.17; price is 2.0% below the high and 36.7% above the low. The VWAP anchored at the 52-week high is $101.17, below price.

Performance

EW returned +10.9% (1 week), +21.2% (1 month), +10.9% (3 months), +27.7% (6 months), +23.2% (1 year), +19.7% (year to date).

About Edwards Lifesciences Corp

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Listed 2000 · 16,000 employees

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 28 – Oct 14
    5 scans
  2. Breaking out now
    Oct 15
    1 scan
  3. Broke out
    Oct 16
    1 scan

Recent news

Congress activity

Disclosed STOCK Act trades in EW · 8 recent

All disclosures →
MemberSideAmount
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · NJ · traded 2025-11-19
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-05-12
Sell$50K–$100K
Bruce Westerman
Bruce Westerman
house · R · AR · traded 2025-04-21
Sell$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-04-08
Buy$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-04-07
Buy$15K–$50K
Bruce Westerman
Bruce Westerman
house · R · AR · traded 2025-03-03
Buy$1K–$15K
Markwayne Mullin
Markwayne Mullin
senate · traded 2024-08-20
Sell$15K–$50K

Insider activity

SEC Form 4 transactions in EW · open-market 5 sells

InsiderSideShares
Chopra Daveen
CVP, TMTT, Surgical & IHFM · Common Stock · 2026-09-11
Tax398
Lippis Daniel J.
CVP, TAVR · Common Stock · 2026-09-11
Exercise619
Lippis Daniel J.
CVP, TAVR · Common Stock · 2026-09-11
Sell619
Lippis Daniel J.
CVP, TAVR · Employee Stock Option (Right to Acquire) · 2026-09-11
Exercise619
Dahl Andrew M.
SVP, Corporate Controller · Common Stock · 2026-08-31
Sell544
Bruls Annette
CVP, EMEACLA · Common Stock · 2026-08-28
Sell2.64K
Chopra Daveen
CVP, TMTT, Surgical & IHFM · Common Stock · 2026-08-26
Exercise31.8K
Chopra Daveen
CVP, TMTT, Surgical & IHFM · Common Stock · 2026-08-26
Sell1.15K
Chopra Daveen
CVP, TMTT, Surgical & IHFM · Common Stock · 2026-08-26
Sell30.65K
Chopra Daveen
CVP, TMTT, Surgical & IHFM · Employee Stock Option (Right to Acquire) · 2026-08-26
Exercise31.8K

SEC filings

EDGAR filings in EW · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.